Term ends Apr 14, 2028 · High confidence
20-year base term ends Apr 14, 2028
Held by Spark Therapeutics, Inc.
Filed Mar 3, 2010 as application 12/595,080 · Granted Sep 4, 2012
Base term, 20 years from filing
Today
2008
2028
Clock starts
Apr 14, 2008
Apr 14, 2008
Term ends
Apr 14, 2028
Apr 14, 2028
Granted
Sep 4, 2012
Sep 4, 2012
base term
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 14, 2008, when application PCT/GB2008/001310, the earliest non-provisional in its chain, was filed (this one was filed Mar 3, 2010) | Apr 14, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 14, 2028 | High confidence |
Partial family
| Application PCT/GB2008/001310 | PCT application no patent term | no patent term |
| US 8,257,969 | this patent Apr 2028 | Apr 2028 |
Partial: 1 of the 2 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 25, 2012 Reel 28433, frame 961 | Farrar, Jane; O'reilly, Mary; Millington-ward, Sophia; Kenna, Paul; Chadderton, Naomi; Humphries, Peter; Palfi, Arpad | The Provost Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth | Assignment of Assignor's Interest |
| Apr 15, 2026 Reel 74376, frame 191 | Spark Therapeutics Ireland Limited | Spark Therapeutics, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Apr 2028
Term ends Apr 14, 2028. No further fees fall due before then
Citations
9
later US patents cite this one
That is above the median of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.